Effects of anastrozole combined with Shuganjiangu decoction on osteoblast-like cell proliferation, differentiation and OPG/RANKL mRNA expression

Yan Ren,Shu-yan Han,Ping-ping Li
DOI: https://doi.org/10.1007/s11670-012-0151-6
2012-01-01
Chinese Journal of Cancer Research
Abstract:Objective To investigate the effects of anastrozole combined with Shuganjiangu decoction on osteoblast-like cells. Methods Human osteoblast-like cells MG-63 were cultured and divided into four groups: control, anastrozole, Shuganjiangu decoction (SGJGD), and anastrozole combined with SGJGD. Cell proliferation was investigated by MTT assay. Alkaline phosphatase (ALP) and osteocalcin, the indicators of cell differentiation, were evaluated by p-nitrophenylphosphate method and radioimmunoassay, respectively. Gene expressions of ALP, osteocalcin, osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) were examined by real-time PCR. Results As evidenced by MTT assay, cell proliferation of MG-63 was inhibited by anastrozole, but stimulated with treatment of SGJGD alone and combined with anastrozole ( P <0.01). Compared with control group, ALP activity was increased by the treatment of SGJGD alone and combined with anastrozole ( P <0.01). Also, osteocalcin secretion was enhanced with the treatment of SGJGD single and combination with anastrozole ( P <0.05). In the real-time PCR assay, gene expressions of ALP and osteocalcin were significantly increased ( P <0.01 for ALP, P <0.05 for osteocalcin) by the treatment of SGJGD and anastrozole combined with SGJGD, but the expression of RANKL was decreased ( P <0.05). Moreover, anastrozole combined with SGJGD upregulated gene expression of OPG ( P <0.01). Conclusion SGJGD may alleviate the injury effects of anastrozole on MG-63 cells through adjusting bone formation and resorption indicators.
What problem does this paper attempt to address?